Loading...

Phibro Animal Health Corporation

PAHC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$55.16
$0.47(0.86%)
U.S. Market opens in NaNh NaNm

Phibro Animal Health Corporation (PAHC) Stock Overview

Explore Phibro Animal Health Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio24.31
EPS (TTM)$2.26
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$56.79
3 Months$54.76
1 Year Target$62.69

PAHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Phibro Animal Health Corporation (PAHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.31 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.86%
5-Day Change
0.31%
1-Month Change
-0.58%
3-Month Change
41.40%
6-Month Change
30.31%
Year-to-Date (YTD) Change
47.64%
1-Year Change
206.10%
3-Year Change
252.69%
5-Year Change
126.25%
All-Time (Max) Change
224.47%

Contact Information

https://www.pahc.com
201 329 7300
Glenpointe Centre East, Teaneck, NJ, 07666-6712

Company Facts

1,940 Employees
IPO DateApr 11, 2014
CountryUS
Actively Trading

Frequently Asked Questions